ATLAS Market profile
Menu
Atlas ¡ Symbols ¡ ETFs ¡ IPOS

Atlas market file ¡ Etf ¡ United States

Renaissance Capital Greenwich FundIPOS

Last close
23.15
Change
-1.10%
96-bar range
17.52 – 26.25
As of
11 Aug 2026

Renaissance Capital Greenwich Fund is an exchange-traded fund listed as IPOS on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot AMEX:IPOS

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

26.511924.198521.88519.571617.258125 Mar03 Jun11 Aug

▮ up candle   ▮ down candle

Latest close23.15
Day change-1.10%
Window high26.25
Window low17.52
96-bar change+24.17%
SnapshotDaily ¡ 96 bars
As of2026-08-11 13:30 UTC

Weekly outlook: the last 104 weekly closes (+73.55% over the window).

26.245211.118826 Aug11 Aug

Source rail: Yahoo Finance chart API (IPOS). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView ¡ provider feed Open view

Open the attributed TradingView market view for IPOS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

IPOS public profile

Company

Exchange-traded fund. Renaissance Capital Greenwich Fund is connected to current market context, cited company sources and its retained research file.

Market

Renaissance Capital Greenwich Fund trades as IPOS on AMEX. Renaissance Capital Greenwich Fund (IPOS) has a latest verified close of 23.15, down 1.10%, dated 11 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. IPOS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

The IPOS ETF landed on Nasdaq this week looking suspiciously like a theme park ride where the queue is longer than the actual slides. Its mandate promises a basket of newly listed stocks-companies that have just completed their IPOs-so investors can gamble on fresh public debuts without the hassle of picking individual floats. But the ride's first loop is a short one: the fund's top ten holdings already account for nearly half the portfolio, and the fee structure quietly hoses away roughly 40 basis points a year for the privilege of riding shotgun on the aftermarket hype train. The Nasdaq ticker screen flashes green, but the fine print whispers that you're paying a premium for a theme that may expire faster than the champagne left on the trading...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Renaissance Capital Greenwich Fund today

Open full report
IPOS daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

IPOS is a Nasdaq-listed ETF that promises exposure to the first-day surge and early aftermarket action of freshly minted public companies. Its mandate isn’t subtle: it tracks an index of IPOs that have just listed on US exchanges, giving investors a way to bet on the post-float pop without having to read S-1 filings or wait for lock-up windows to expire. The fund rebalances quarterly, swapping out the IPOs that have grown too large and sliding in the next cohort of debutantes. Nasdaq lists the ticker and the price in real time, but the real action is in the index methodology, a document so dry it makes prospectuses look like beach reading. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ipos)

The fund’s top ten holdings currently lean heavily toward the usual tech and biotech suspects that dominate every IPO cycle, so the “fresh capitalisation” theme is more of a concentrated bet than a broad innovation sweep. The issuer’s marketing slides call it a “capitalisation revolution,” yet the portfolio’s concentration means a single large-cap IPO can swing the fund’s performance more than any thematic narrative. The glossy pitch is loud, but the portfolio speaks in a spreadsheet-one that refreshes only four times a year and charges you 0.40% annually for the privilege. (source: SEC EDGAR fund search for IPOS, https://www.sec.gov/edgar/search/#/q=IPOS)

SEC filings show the fund’s index provider updates the roster mechanically, using a set of liquidity and market-cap rules that are publicly documented but not exactly investor-friendly. The methodology page exists, but it’s buried in a 200-page PDF that reads like it was translated from corporate legalese by a robot with a thesaurus. Meanwhile, the fund’s issuer is happy to talk about “fresh capitalisation” in investor calls while quietly highlighting the fee in the fine print-because the real capitalisation story here is the one inside the fund’s annual expense ratio. (source: SEC EDGAR fund search for IPOS, https://www.sec.gov/edgar/search/#/q=IPOS)

For liquidity and cost context, FINRA’s Fund Analyzer shows IPOS trading with tight spreads and healthy daily volume, but the numbers reflect the same mega-cap IPOs that dominate every thematic ETF chasing the same story. The fund’s expense ratio sits at 0.40%, which may not sound like much until you run it against a plain-vanilla S&P 500 ETF at 0.03% and wonder how many “fresh capitalisation” parades you’d need to justify the premium. The chart route on Nasdaq shows the price action, but the real story is in the basket’s composition and the fee’s persistence-two facts the issuer’s marketing prefers to keep in the background. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

The fund’s current roster is a who’s who of recent IPOs, but the concentration risk is plain: if the top three holdings lag in their first year, the fund’s headline return will read more like a cautionary tale than a capitalisation revolution. The issuer’s pitch deck calls it a “diversified innovation engine,” yet the SEC filings reveal a quarterly rebalancing act that is anything but diversified. The fund’s liquidity is strong, but liquidity in IPOs is a bit like a fireworks show-spectacular on the way up and messy on the way down. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ipos; SEC EDGAR fund search for IPOS, https://www.sec.gov/edgar/search/#/q=IPOS)

What remains unproven is whether the fund’s quarterly rebalancing can consistently capture the post-IPO pop without being diluted by the fee drag. The issuer’s marketing leans on the idea of “fresh capitalisation,” but the reality is a mechanical index that trades on liquidity and market-cap rules-not investor insight. The fund’s expense ratio is its most predictable feature: it arrives every year like clockwork, while the IPOs it holds arrive and depart with the same mechanical regularity. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

To deepen the file, we’d need the fund’s latest holdings list, the index provider’s full methodology, and a side-by-side comparison of IPOS’s performance against a peer group of plain-vanilla index funds over a full market cycle. Until then, the fund’s story is less a capitalisation revolution and more a high-fee carousel spinning on the same IPO horses. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ipos; SEC EDGAR fund search for IPOS, https://www.sec.gov/edgar/search/#/q=IPOS)

Sources & evidence ¡ 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
IPOS
Exchange
AMEX
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

IPOS technical readout

Trend strength (ADX 14)
19.4
Average true range (ATR 14)
0.653
ATR as % of price
2.98%
Volatility compression (ATR14/ATR50)
1.02x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

IPOS evidence rails

Atlas uses the specific public rails available for IPOS: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence ¡ 4 rails

Open an Atlas research path on IPOS

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for IPOS Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep IPOS research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

IPOS FAQ

What is Renaissance Capital Greenwich Fund (IPOS)?Renaissance Capital Greenwich Fund (IPOS) has a latest verified close of 23.15, down 1.10%, dated 11 Aug 2026. Use this page to check the price chart, company context,...

Renaissance Capital Greenwich Fund (IPOS) has a latest verified close of 23.15, down 1.10%, dated 11 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for IPOS?Renaissance Capital Greenwich Fund (IPOS) has a latest verified close of 23.15, down 1.10%, dated 11 Aug 2026. It brings the latest available chart, company context,...

Renaissance Capital Greenwich Fund (IPOS) has a latest verified close of 23.15, down 1.10%, dated 11 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. IPOS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the IPOS page updated?The IPOS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The IPOS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for IPOS?The IPOS file starts with Nasdaq Trader and TradingView AMEX:IPOS. The page separates verified market context from company evidence and shows open evidence gaps instead...

The IPOS file starts with Nasdaq Trader and TradingView AMEX:IPOS. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on IPOS?Yes. The workstation can open IPOS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open IPOS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this IPOS page investment advice?No. The IPOS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The IPOS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →